A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2366 participants.

Also called NCT03766581

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Phase 2
Enrolled
  • 2,366 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03766581
Other papers using this trial's data
  • Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial The Lancet. Neurology, 2024-01 DOI, PubMed 38101902, PMC10822143 In the PMC Open Access subset under a licence that is not Creative Commons.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Greece, Hong Kong SAR China, Hungary, Israel, Italy, Japan, Mexico, Norway, Poland, Russia, South Korea, Spain, Sweden, Switzerland, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03766581. Randomized; quadruple masking; primary purpose prevention. Start 2019-01-27 (actual); primary completion 2022-03-31 (actual). Results posted on 2023-06-12.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study on BMS-986177 for the Prevention of a Stroke in Patients Receiving Aspirin and Clopidogrel
Acronym
AXIOMATIC-SSP
Condition
Acute Ischemic Stroke
Intervention (Drug)
BMS-986177
Intervention (Other)
Placebo
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Aspirin
Lead sponsor
Bristol-Myers Squibb (class: industry)
Collaborator
Janssen, LP (class: industry)

Record details

Record id
cardio:ct-nct03766581
Content hash
e71004eb0efabb464b7dc81a9aa6542b79e978553344e949ecb4b6fa4c294d11